The deep brain stimulation systems global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Deep Brain Stimulation Systems Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The deep brain stimulation systems market size has grown rapidly in recent years. It will grow from $2.28 billion in 2023 to $2.53 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rising desire for less invasive operations among the general public, increasing demand for minimally invasive surgery in developed countries, rising demand for minimally invasive surgical procedures, high prevalence of diseases such as parkinson’s disease and epilepsy, increasing prevalence of neurological disorders.
The deep brain stimulation systems market size is expected to see rapid growth in the next few years. It will grow to $3.76 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing growth in the geriatric population, rising prevalence of neurological disorders globally, growing aging population, increasing acceptance of neurostimulation therapies, rising healthcare infrastructure development. Major trends in the forecast period include technological advancements in deep brain stimulation devices, advancements in technology, focus on non-motor symptoms, miniaturization and advanced materials, wireless connectivity and remote monitoring, multimodal therapies.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-systems-global-market-report
Scope Of Deep Brain Stimulation Systems Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Deep Brain Stimulation Systems Market Overview
Market Drivers –
The increasing prevalence of neurological disorders is expected to propel the growth of the deep brain stimulation systems market going forward. Neurological disorders refer to a group of heterogeneous diseases that affect the body’s autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are used in neurosurgical procedures to send electrical stimulation to the desired area, aiming to alter or modulate neural functioning and achieve a reversible, adjustable, and therapeutic effect. For instance, in March 2023, according to the Parkinson’s Foundation, a US-based national organization, nearly 90,000 people were diagnosed with PD every year in the US, a 50% increase from the previously estimated rate of 60,000 diagnoses annually. For instance, in October 2022, according to the Centers for Disease Control and Prevention, a US-based federal agency, up to 5.8 million Americans suffered from Alzheimer’s disease in 2020, and this population is expected to almost triple to 14 million by 2060. Therefore, the increasing prevalence of neurological disorders is driving the growth of the deep brain stimulation systems market.
Market Trends –
Major companies operating in the deep brain stimulation systems market are developing innovative technology, such as deep brain stimulation (DBS) systems, to treat patients with movement disorders. Deep Brain Stimulation (DBS) is a medical procedure that involves an implanted device that delivers an electrical current directly to areas of the brain. For instance, in January 2024, Abbott Laboratories, a US-based medical devices and health care company, launched the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people living with movement disorders. The Liberta RC DBS system is the only rechargeable, first-of-its-kind connected care technology in the U.S. and enables patients to stay in touch with their physicians, guarantee optimal configuration and operation, and obtain updated treatment settings remotely when necessary without having to visit a physician’s office.
The deep brain stimulation systems market covered in this report is segmented –
1) By Product: Single Channel, Dual Channel
2) By Application: Parkinson’s Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, Other Applications
3) By End-user: Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Other End Users
Get an inside scoop of the deep brain stimulation systems market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13834&type=smp
Regional Insights –
North America was the largest region in the deep brain stimulation systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Quest Diagnostics Inc., St. Jude Medical Inc., Stanford Health Care, Associated Regional and University Pathologists Inc., LivaNova PLC, OPKO Health Inc., Nordic Laboratories, Myriad Genetics Inc., Nevro Corporation, Genomic Health, Mayo Medical Laboratories, Foundation Medicine Inc., SceneRay Co., ACM Global Laboratories, Neuropace Inc., American Esoteric Laboratories, Nexstim Oy, Aleva Neurotherapeutics S.A., NeuroSigma Inc., Beijing PINS Medical Co. Ltd., BioMONTR Labs, Functional Neuromodulation Ltd., Miraca Holdings Inc., Nuvectra Corporation
Table of Contents
1. Executive Summary
2. Deep Brain Stimulation Systems Market Characteristics
3. Deep Brain Stimulation Systems Market Trends And Strategies
4. Deep Brain Stimulation Systems Market – Macro Economic Scenario
5. Global Deep Brain Stimulation Systems Market Size and Growth
….
32. Global Deep Brain Stimulation Systems Market Competitive Benchmarking
33. Global Deep Brain Stimulation Systems Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Deep Brain Stimulation Systems Market
35. Deep Brain Stimulation Systems Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
